Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |